NCT01418066

Brief Summary

In the present study the investigators are trying to evaluate the effect of Murraya koenigii leaves, Punica granatum and Curcuma which is administered to the patients in a combined form as tea. This study will help to evaluate the effect of these preparations scientifically in improving the IBS symptoms.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2011

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2011

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

August 15, 2011

Completed
1 day until next milestone

First Posted

Study publicly available on registry

August 16, 2011

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2012

Completed
Last Updated

December 6, 2012

Status Verified

December 1, 2012

Enrollment Period

1.3 years

First QC Date

August 15, 2011

Last Update Submit

December 5, 2012

Conditions

Outcome Measures

Primary Outcomes (1)

  • irritable bowel syndrome- symptom severity score

    IBS-SSS(Francis, 1997)

    T2 (Day 28)

Secondary Outcomes (9)

  • Frequency of abdominal discomfort/Pain

    last week of treatment (days 21-28)

  • Intensity of Abdominal Pain/Discomfort

    Last week of treatment (days 21-28)

  • Stool and diarrhea Frequency

    last week of treatment (days 21-28)

  • Quality of life

    T2 (Day 28)

  • IBS Specific Quality of life

    T2 (Day 28)

  • +4 more secondary outcomes

Study Arms (2)

Placebo

PLACEBO COMPARATOR

Tea decoction made of Graminis Flores abd Maidis stigmata.

Drug: Placebo tea

Ayurvedic herbs

EXPERIMENTAL

Tea decoction made of Murraya koenigii leaves, Punica granatum and Curcuma

Drug: Ayurvedic Herbs

Interventions

A tea made of Murraya koenigii leaves, Punica granatum and Curcuma as powder. Decoction of 12ml powder in 100ml hot water is taken twice daily at least 30 minutes before a meal.

Ayurvedic herbs

Graminis Flores and Maidis stigmata as a powder. Decoction made of 12ml in 100ml hot water. To drink twice daily at least 30 Minutes before a meal.

Placebo

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Irritable Bowel Syndrome according to Rom-III
  • Subtype Diarrhea or Alternating
  • discomfort or pain \> 1 times a week
  • discomfort or pain \> 4 on a Visual Analog Scale

You may not qualify if:

  • Inflammatory bowel diseases (test results necessary)
  • Lactose, Fructose Malabsorption (test results necessary)
  • Celiac Disease
  • Pregnancy or Breastfeeding
  • Colectomy or Hemicolectomy \>50cm
  • Severe metabolic disorders, hormonal disorders, cardiac or respiratory failure, liver or renal diseases
  • severe depression, psychotic or psychiatric disorders, substance abuse
  • cancer within the last 5 years
  • allergy to caraway
  • acute inflammatory diseases

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Klinik für Naturheilkunde und Integrative Medizin

Essen, North Rhine-Westphalia, 45276, Germany

Location

MeSH Terms

Conditions

Irritable Bowel Syndrome

Condition Hierarchy (Ancestors)

Colonic Diseases, FunctionalColonic DiseasesIntestinal DiseasesGastrointestinal DiseasesDigestive System Diseases

Study Officials

  • Jost Langhorst, Prof., MD

    University Duisburg-Essen, Chair of Integrative Gastroenterology

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof. Dr.

Study Record Dates

First Submitted

August 15, 2011

First Posted

August 16, 2011

Study Start

August 1, 2011

Primary Completion

December 1, 2012

Study Completion

December 1, 2012

Last Updated

December 6, 2012

Record last verified: 2012-12

Locations